PF614 capsule

DRUG2 trials

Sponsors

Ensysce Biosciences

Conditions

PharmacokineticsPostoperative Pain, Acute

Phase 1

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

RecruitingNCT06500793

Ensysce BiosciencesPharmacokinetics

Start: 2024-11-24End: 2026-12-31Target: 30Updated: 2026-03-06

Phase 3

PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)

RecruitingNCT06602271

Ensysce BiosciencesPostoperative Pain, Acute

Start: 2025-12-09End: 2026-11-01Target: 320Updated: 2026-01-22